Mometasone furoate
Nasonex nasal spray contains mometasone furoate, which belongs to a group of medicines called corticosteroids. Mometasone furoate administered intranasally relieves symptoms of inflammation (swelling and irritation of the nasal mucosa), sneezing, itching, and a stuffy nose, and reduces the amount of nasal discharge.
Hay fever and perennial allergic rhinitis Nasonex is used to treat symptoms of hay fever (also known as seasonal allergic rhinitis) and perennial allergic rhinitis in adults and children aged 3 and older. Hay fever, which occurs at certain times of the year, is an allergic reaction caused by inhaling pollen from trees, grasses, weeds, as well as mold and fungal spores. Perennial allergic rhinitis occurs throughout the year, and symptoms can be caused by sensitivity to various factors, including house dust mites, animal dander (or shed skin), feathers, and some foods. Nasonex reduces swelling and irritation of the nasal mucosa, thereby relieving sneezing, itching, stuffy nose, or nasal discharge caused by hay fever or perennial allergic rhinitis. Nasal polyps Nasonex is used to treat nasal polyps in adults aged 18 and older. Nasal polyps are small growths on the nasal mucosa, usually occurring in both nostrils. Nasonex reduces inflammation in the nose, causing gradual reduction of nasal polyps, thereby reducing the feeling of a stuffy nose, which can make breathing difficult.
Before starting to use Nasonex, you should discuss it with your doctor or pharmacist:
While using Nasonex, you should discuss it with your doctor
If corticosteroids in the form of a nasal spray are taken in large doses for a long time, side effects may occur due to the absorption of the medicine into the body. If you experience itching or irritation of the eyes, your doctor may prescribe a different treatment with Nasonex. If you experience blurred vision or other vision disturbances, you should contact your doctor.
If corticosteroids in the form of a nasal spray are taken in large doses for a long time, they may cause certain side effects, such as slowing down the growth rate in children. It is recommended that the growth of children receiving long-term treatment with nasal corticosteroids be regularly monitored, and if any changes are observed, the doctor should be informed.
You should tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take, including those that are available without a prescription. If you are taking other corticosteroids orally or by injection to treat allergies, your doctor may advise you to stop taking them when you start using Nasonex. In some patients, after stopping oral or injectable corticosteroids, side effects such as joint or muscle pain, weakness, and depression may occur. Other allergic symptoms, such as itching, tearing of the eyes, or red and itchy spots on the skin, may also appear. You should contact your doctor if you experience any of these symptoms. Some medicines may enhance the effect of Nasonex, and your doctor may want to monitor your condition closely if you are taking such medicines (including certain HIV medicines: ritonavir, cobicistat).
There are no data or only limited data on the use of Nasonex in pregnant women. It is not known whether mometasone furoate passes into breast milk. If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before using this medicine.
There are no data on the effect of Nasonex on the ability to drive and use machines.
Benzalkonium chloride may cause irritation or swelling inside the nose, especially if used for a long time.
Nasonex should always be used as directed by your doctor. If you are unsure, consult your doctor or pharmacist. The nasal spray should not be used more frequently, for a longer period, or in larger doses than prescribed by your doctor.
In some patients, relief of symptoms occurs within 12 hours of administration of the first dose of Nasonex; however, full benefits of treatment may not be observed until after 2 days of treatment. Therefore, you should continue to use the spray regularly to achieve full benefits from treatment. If you have severe symptoms of hay fever, it may be necessary to start using Nasonex a few days before the expected start of the pollen season. This will help prevent the occurrence of hay fever symptoms.
Nasonex nasal spray contains a protective cap that protects the tip of the actuator and prevents it from becoming contaminated. Remember to remove it before use and replace it after use. Before first use, check the functioning of the spray by pressing the pump 10 times until a fine mist is produced:
After use, gently wipe the actuator with a clean tissue or cloth and replace the protective cap.
Page 4 of 7 Cleaning
If you accidentally use a higher dose of Nasonex than recommended, you should consult your doctor. If steroids are used for a long period or in large doses, they may have an adverse effect on your hormones. In children, they may affect growth and development.
If you forget to use the nasal spray at the right time, you should use it as soon as you remember, and then continue treatment at the usual time. Do not use a double dose to make up for a missed dose.
In some patients, relief of symptoms occurs within 12 hours of administration of the first dose of Nasonex; however, full benefits of treatment may not be observed until after 2 days of treatment. It is very important that you use the nasal spray regularly. You should not stop treatment, even if you feel better, unless your doctor advises you to do so. If you have any further doubts about using this medicine, you should consult your doctor or pharmacist.
Like all medicines, Nasonex can cause side effects, although not everybody gets them. After using this medicine, immediate allergic reactions (hypersensitivity) may occur. These reactions can be severe. You should stop using Nasonex and seek medical help immediately if you experience symptoms such as:
If corticosteroids in the form of a nasal spray are taken in large doses for a long time, side effects may occur due to the absorption of the medicine into the body. Other side effects Page 5 of 7 Most people using nasal sprays do not report any side effects. However, some people using Nasonex or other corticosteroids in the form of a nasal spray have reported the following side effects:
Frequency not known (frequency cannot be estimated from the available data):
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products Al. Jerozolimskie 181C PL-02 222 Warsaw Tel.: + 48 22 49 21 301 Fax: + 48 22 49 21 309 Website: https://smz.ezdrowie.gov.pl. By reporting side effects, you can help provide more information on the safety of this medicine.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Page 6 of 7
Nasonex is a nasal spray, suspension. Each bottle contains 140 doses of the medicine. For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Organon Belgium, Handelsstraat 31/Rue du Commerce 31, B-1000 Brussels, Belgium
NV Schering-Plough Labo, Industriepark 30, B-2220 Heist-op-den-Berg, Belgium
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź Belgian marketing authorization number: BE190854
Austria: Nasonex aquosum-Nasenspray Belgium, Croatia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Slovenia, Sweden, United Kingdom: Nasonex Bulgaria, Czech Republic, Romania, Slovakia: NASONEX Latvia: Nasonex 50 mikrogrami/deva deguna aerosols, suspensija Portugal: Nasomet Spain: NASONEX 50 microgramos suspensión para pulverización nasal Date of approval of the leaflet: 14.04.2022[Information about the trademark] Page 7 of 7
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.